ARGX vs. ISRG: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ARGX and ISRG, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ISRG stands out with 196.08 billion USD in market value—about 5.49× ARGX’s market cap of 35.72 billion USD.
ISRG carries a higher beta at 1.70, indicating it’s more sensitive to market moves, while ARGX remains steadier at 0.17.
ARGX trades as an ADR, giving U.S. investors a simple on-ramp to its foreign shares, while ISRG remains a standard domestic listing.
| Symbol | ARGX | ISRG |
|---|---|---|
| Company Name | argenx SE | Intuitive Surgical, Inc. |
| Country | NL | US |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical - Instruments & Supplies |
| CEO | Mr. Timothy Van Hauwermeiren EMBA, M.Sc. | Dr. Gary S. Guthart Ph.D. |
| Price | 584.95 USD | 547.07 USD |
| Market Cap | 35.72 billion USD | 196.08 billion USD |
| Beta | 0.17 | 1.70 |
| Exchange | NASDAQ | NASDAQ |
| IPO Date | May 18, 2017 | June 16, 2000 |
| ADR | Yes | No |
Performance Comparison
This chart compares the performance of ARGX and ISRG over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of ARGX and ISRG based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- ARGX has a negative Price-to-Free Cash Flow ratio of -455.63, signaling it consumed more cash than it produced over the last year—an important liquidity warning. In contrast, ISRG (P/FCF 112.35) indicates positive free cash flow generation.
| Symbol | ARGX | ISRG |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 51.04 | 78.99 |
| Forward PEG Ratio (TTM) | 1.35 | 5.02 |
| Price-to-Sales Ratio (P/S, TTM) | 16.49 | 22.50 |
| Price-to-Book Ratio (P/B, TTM) | 7.74 | 11.43 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | -455.63 | 112.35 |
| EV-to-EBITDA (TTM) | 4569.26 | 64.49 |
| EV-to-Sales (TTM) | 15.83 | 22.20 |
| EV-to-Free Cash Flow (TTM) | -437.47 | 110.87 |
Dividend Comparison
Neither ARGX nor ISRG currently pays a dividend yield; this often indicates they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.
| Symbol | ARGX | ISRG |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ARGX and ISRG, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- ARGX has negative EBIT (interest coverage -20.85), unable to cover interest, while ISRG shows “--” (negligible interest expense).
| Symbol | ARGX | ISRG |
|---|---|---|
| Current Ratio (TTM) | 7.29 | 4.98 |
| Quick Ratio (TTM) | 6.68 | 3.97 |
| Debt-to-Equity Ratio (TTM) | 0.01 | 0.00 |
| Debt-to-Assets Ratio (TTM) | 0.01 | 0.00 |
| Interest Coverage Ratio (TTM) | -20.85 | -- |